{"id":115514,"date":"2025-12-11T09:47:00","date_gmt":"2025-12-11T08:47:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=115514"},"modified":"2025-12-11T08:34:15","modified_gmt":"2025-12-11T07:34:15","slug":"amplifold-seed-funding","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/115514\/amplifold-seed-funding\/","title":{"rendered":"Amplifold raises 5 million euros"},"content":{"rendered":"
\n

Amplifold, a LMU Munich spin-off<\/a>, closes an oversubscribed seed funding round of five million euros. Matterwave Ventures and Xista Science Ventures lead the consortium, with participation from Bayern Kapital, b2venture, and Becker Ventures. The team is moving into the Innovation and Start-up Center for Biotechnology (IZB)<\/a> to Martinsried and is expanding product development and regulatory activities there \u2013 with the aim of bringing the first in-vitro diagnostic product through the European IVDR certification.<\/p>\n\n\n\n

The technology is based on a DNA origami approach recently described in Nature Communications. The nanostructures significantly increase the sensitivity of classic lateral flow assays (LFAs) without altering the simple, cost-effective test format. Amplifold thus addresses a key problem: the low sensitivity of many rapid tests, which has so far led to false diagnoses and additional PCR tests in the rapidly growing point-of-care diagnostics market.<\/p>\n\n\n\n

\n

\u201cLateral flow tests have revolutionized access to diagnostics, but their sensitivity has traditionally lagged behind central laboratory systems. DNA origami signal amplification enables cost-effective rapid tests that achieve instrument-level sensitivity without changing the basic format.\u201d<\/p>\n<\/blockquote>\n\n\n\n

explained Maximilian Urban<\/strong>, Co-founder, co-inventor and CEO of Amplifold.<\/p>\n\n\n\n

Enzo Kopperger<\/strong>, also co-founder and managing director, adds:<\/p>\n\n\n\n

\n

\u201cWhat makes Amplifold unique is that we can offer up to 100 times higher analytical sensitivity at essentially the same manufacturing costs as conventional LFAs. Our architecture is designed to integrate into existing manufacturing processes, allowing partners to quickly upgrade their assays instead of developing their product lines from scratch.\u201d<\/p>\n<\/blockquote>\n\n\n\n

Significance for the diagnostics market<\/h2>\n\n\n\n

The technology was developed in the nanoengineering laboratory of LMU professor Tim Liedl<\/strong>He categorizes the development as follows:<\/p>\n\n\n\n

\n

\u201cOver the past few years, our group has worked to transform DNA origami from a beautiful scientific concept into a robust toolbox for nanotechnology. The Amplifold team has been at the forefront of translating these advances into real diagnostic applications. It is very gratifying to see a technology developed and fostered in our lab now making its way into the clinic and the market with the support of a strong consortium of investors.\u201d<\/p>\n<\/blockquote>\n\n\n\n

Investors also emphasize the market potential. Benedict Kronberger<\/strong>, partner at Matterwave Ventures, says:<\/p>\n\n\n\n

\n

\u201cAmplifold is exactly the kind of industrial deep tech company we are looking for: a fundamental breakthrough applied to a huge, existing market. The fact that this funding round was significantly oversubscribed speaks to the quality of the team and the commercial clarity of the opportunity. We are very excited to support Amplifold and to join the board.\u201d<\/p>\n<\/blockquote>\n\n\n\n

And Monika Steger<\/strong>, Managing Director at Bayern Kapital, also sees a technological breakthrough:<\/p>\n\n\n\n

\n

\u201cAmplifold\u2019s DNA origami technology has the potential to fundamentally change rapid diagnostic tests \u2013 delivering lab-level accuracy in minutes, up to 100 times higher analytical sensitivity, and direct point-of-care testing. As a long-term partner of innovative med and deeptech pioneers, we are excited to embark on this journey together and actively shape the next generation of diagnostics.\u201d<\/p>\n<\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"

Munich-based startup Amplifold receives five million euros for the further development of its DNA origami technology, which is intended to make rapid medical tests significantly more sensitive.<\/p>","protected":false},"author":42,"featured_media":115516,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[5486,371,52,4321],"acf":[],"yoast_head":"\nAmplifold holt 5 Millionen Euro - Munich Startup<\/title>\n<meta name=\"description\" content=\"Amplifold erh\u00e4lt 5 Millionen Euro f\u00fcr ultrasensitive DNA-Origami-Schnelltests und treibt Produktentwicklung sowie IVDR-Zulassung voran.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/115514\/amplifold-seed-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amplifold holt 5 Millionen Euro - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Amplifold erh\u00e4lt 5 Millionen Euro f\u00fcr ultrasensitive DNA-Origami-Schnelltests und treibt Produktentwicklung sowie IVDR-Zulassung voran.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/115514\/amplifold-seed-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-11T08:47:00+00:00\" \/>\n<meta name=\"author\" content=\"Saskia Doll\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saskia Doll\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/\",\"url\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/\",\"name\":\"Amplifold holt 5 Millionen Euro - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg\",\"datePublished\":\"2025-12-11T08:47:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\"},\"description\":\"Amplifold erh\u00e4lt 5 Millionen Euro f\u00fcr ultrasensitive DNA-Origami-Schnelltests und treibt Produktentwicklung sowie IVDR-Zulassung voran.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg\",\"width\":748,\"height\":420,\"caption\":\"Amplifold\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amplifold holt 5 Millionen Euro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\",\"name\":\"Saskia Doll\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"caption\":\"Saskia Doll\"},\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/doll\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"748\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amplifold raises 5 million euros - Munich Startup","description":"Amplifold receives 5 million euros for ultrasensitive DNA origami rapid tests and is pushing ahead with product development and IVDR approval.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/115514\/amplifold-seed-funding\/","og_locale":"en_US","og_type":"article","og_title":"Amplifold holt 5 Millionen Euro - Munich Startup","og_description":"Amplifold erh\u00e4lt 5 Millionen Euro f\u00fcr ultrasensitive DNA-Origami-Schnelltests und treibt Produktentwicklung sowie IVDR-Zulassung voran.","og_url":"https:\/\/cms.munich-startup.net\/en\/115514\/amplifold-seed-funding\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2025-12-11T08:47:00+00:00","author":"Saskia Doll","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Saskia Doll","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/","url":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/","name":"Amplifold raises 5 million euros - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg","datePublished":"2025-12-11T08:47:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5"},"description":"Amplifold receives 5 million euros for ultrasensitive DNA origami rapid tests and is pushing ahead with product development and IVDR approval.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg","width":748,"height":420,"caption":"Amplifold"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/115514\/amplifold-seed-finanzierung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Amplifold holt 5 Millionen Euro"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5","name":"Saskia Doll","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","caption":"Saskia Doll"},"url":"https:\/\/cms.munich-startup.net\/en\/author\/doll\/"}]},"og_image":[{"width":748,"height":420,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2025\/12\/Amplifold2.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1765438456:25","_edit_last":"25","_yoast_wpseo_focuskw":"Amplifold","_yoast_wpseo_metadesc":"Amplifold erh\u00e4lt 5 Millionen Euro f\u00fcr ultrasensitive DNA-Origami-Schnelltests und treibt Produktentwicklung sowie IVDR-Zulassung voran.","_yoast_wpseo_linkdex":"78","_thumbnail_id":"115516","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"90","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"Das Team von Amplifold (v. l. n. r.): Dr. Heini Ija\u0308s, Dr. Gabriela de Melo, Prof. Tim Liedl, Dr. Enzo Kopperger, Dr. Julian Trommler, Dr. Maximilian Urban, Dr. Federico Buersgens","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"1","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/115514"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=115514"}],"version-history":[{"count":3,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/115514\/revisions"}],"predecessor-version":[{"id":115519,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/115514\/revisions\/115519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/115516"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=115514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=115514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=115514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}